An expert panel of India’s drugs regulator may next week consider approving Covovax, the second Covid-19 vaccine developed by the Serum Institute of India, to be used as a booster dose, according to people familiar with the matter. Read More
An expert panel of India’s drugs regulator may next week consider approving Covovax, the second Covid-19 vaccine developed by the Serum Institute of India, to be used as a booster dose, according to people familiar with the matter.